East Ocyon Bio is a biotechnology company focused on harnessing the power of natural killer (NK) cells for cancer treatment. It specializes in developing cell and gene therapies that modify NK cells using synthetic biology and non-viral cell engineering. The company's innovative approach creates allogeneic chimeric antigen receptors, enabling NK cells to recognize and attack both solid and blood-based tumors, thereby enhancing the immune system's response to cancer. This results in advanced treatment options for various types of cancer, providing doctors with effective tools to combat the disease.
Swipha
Acquisition in 2024
Swiss Pharma Nigeria (Swipha) manufactures, markets, and distributes pharmaceutical products that meet international standards.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.